Discontinuation of Denosumab and Associated Fracture Incidence: Analysis From the Fracture Reduction Evaluation of Denosumab in Osteoporosis Every 6 Months (FREEDOM) Trial
暂无分享,去创建一个
Jacques P. Brown | A. Grauer | C. Roux | Andrea T Wang | C. Recknor | M. Austin | P. Ho | R. Wagman | N. Gilchrist | O. Törring | J. Beck Jensen